Cargando…

Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature

BACKGROUND AND AIM OF THE WORK: Several studies have shown beneficial effects for Platelet-rich plasma (PRP). We aimed to assess the efficacy of pure PRP injection for facial rejuvenation in Iran. METHODS: 30 female consecutive participants were injected with PRP in two sessions with 3 month interva...

Descripción completa

Detalles Bibliográficos
Autores principales: Banihashemi, Mahnaz, Zabolinejad, Naghmeh, Salehi, Maryam, Hamidi Alamdari, Zaryoush, Nakhaizadeh, Solmaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182581/
https://www.ncbi.nlm.nih.gov/pubmed/33988167
http://dx.doi.org/10.23750/abm.v92i2.9687
_version_ 1783704237732003840
author Banihashemi, Mahnaz
Zabolinejad, Naghmeh
Salehi, Maryam
Hamidi Alamdari, Zaryoush
Nakhaizadeh, Solmaz
author_facet Banihashemi, Mahnaz
Zabolinejad, Naghmeh
Salehi, Maryam
Hamidi Alamdari, Zaryoush
Nakhaizadeh, Solmaz
author_sort Banihashemi, Mahnaz
collection PubMed
description BACKGROUND AND AIM OF THE WORK: Several studies have shown beneficial effects for Platelet-rich plasma (PRP). We aimed to assess the efficacy of pure PRP injection for facial rejuvenation in Iran. METHODS: 30 female consecutive participants were injected with PRP in two sessions with 3 month interval. Evaluations were performed by comparing the pre- and post-improvement measurements of skin scan, before after photography by participants, therapeutic physician and blindly by a second dermatologist. RESULTS: In 3 and 6 months follow-ups respectively, moderate to excellent improvement in periorbital dark circles (47.8,60.9%), periorbital wrinkles (73.9%,78.3%), nasolabial fold (52.2%,56.6%) and skin rigidity (52.3%,60.9%) reported by patients, was statistically significant only for dark circle(P value 0.031). Moderate to good improvement in periorbital dark circles (47.9%,74%), periorbital wrinkles (39.1%,43.5%)and nasolabial folds (4.3% ,13.1%) demonstrated by therapeutic physician‘s evaluation, was statistically significant for dark circle (P value 0.008) and nasolabial folds (P value 0.025). Moderate to good improvement in periorbital dark circles (34.8%, 52.2%), periorbital wrinkles (26.1%, 34.8%) and nasolabial folds (4.4%, 13%) by second dermatologist, was statistically significant for dark circle (P value 0.025). CONCLUSION: Face rejuvenation with PRP is a promising and noninvasive technique with best results observed in improving periorbital dark circles and wrinkles. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-8182581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-81825812021-06-16 Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature Banihashemi, Mahnaz Zabolinejad, Naghmeh Salehi, Maryam Hamidi Alamdari, Zaryoush Nakhaizadeh, Solmaz Acta Biomed Original Article BACKGROUND AND AIM OF THE WORK: Several studies have shown beneficial effects for Platelet-rich plasma (PRP). We aimed to assess the efficacy of pure PRP injection for facial rejuvenation in Iran. METHODS: 30 female consecutive participants were injected with PRP in two sessions with 3 month interval. Evaluations were performed by comparing the pre- and post-improvement measurements of skin scan, before after photography by participants, therapeutic physician and blindly by a second dermatologist. RESULTS: In 3 and 6 months follow-ups respectively, moderate to excellent improvement in periorbital dark circles (47.8,60.9%), periorbital wrinkles (73.9%,78.3%), nasolabial fold (52.2%,56.6%) and skin rigidity (52.3%,60.9%) reported by patients, was statistically significant only for dark circle(P value 0.031). Moderate to good improvement in periorbital dark circles (47.9%,74%), periorbital wrinkles (39.1%,43.5%)and nasolabial folds (4.3% ,13.1%) demonstrated by therapeutic physician‘s evaluation, was statistically significant for dark circle (P value 0.008) and nasolabial folds (P value 0.025). Moderate to good improvement in periorbital dark circles (34.8%, 52.2%), periorbital wrinkles (26.1%, 34.8%) and nasolabial folds (4.4%, 13%) by second dermatologist, was statistically significant for dark circle (P value 0.025). CONCLUSION: Face rejuvenation with PRP is a promising and noninvasive technique with best results observed in improving periorbital dark circles and wrinkles. (www.actabiomedica.it) Mattioli 1885 2021 2021-05-12 /pmc/articles/PMC8182581/ /pubmed/33988167 http://dx.doi.org/10.23750/abm.v92i2.9687 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Banihashemi, Mahnaz
Zabolinejad, Naghmeh
Salehi, Maryam
Hamidi Alamdari, Zaryoush
Nakhaizadeh, Solmaz
Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title_full Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title_fullStr Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title_full_unstemmed Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title_short Platelet-rich Plasma use for facial rejuvenation: a clinical trial and review of current literature
title_sort platelet-rich plasma use for facial rejuvenation: a clinical trial and review of current literature
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182581/
https://www.ncbi.nlm.nih.gov/pubmed/33988167
http://dx.doi.org/10.23750/abm.v92i2.9687
work_keys_str_mv AT banihashemimahnaz plateletrichplasmauseforfacialrejuvenationaclinicaltrialandreviewofcurrentliterature
AT zabolinejadnaghmeh plateletrichplasmauseforfacialrejuvenationaclinicaltrialandreviewofcurrentliterature
AT salehimaryam plateletrichplasmauseforfacialrejuvenationaclinicaltrialandreviewofcurrentliterature
AT hamidialamdarizaryoush plateletrichplasmauseforfacialrejuvenationaclinicaltrialandreviewofcurrentliterature
AT nakhaizadehsolmaz plateletrichplasmauseforfacialrejuvenationaclinicaltrialandreviewofcurrentliterature